Updates on Advanced Therapies for Acute Pulmonary Embolism
Journal: International Journal of Cardiovascular Practice (Vol.1, No. 3)Publication Date: 2016-10-01
Authors : Bavand Bikdeli; Behnood Bikdeli;
Page : 47-50
Keywords : ;
Abstract
Venous thromboembolism is the third common vascular disease after acute myocardial infarction and stroke, and acute pulmonary embolism (PE) remains as the most common preventable cause of in-hospital mortality. In addition to routine anticoagulant therapy, several advanced treatment options have been introduced over the past three decades. We provide a succinct and contemporary summary of the evidence base and important indications for inferior vena caval filter placement, systemic and catheter-based thrombolytic therapy, as well as percutaneous and surgical thrombectomy. Appropriate case selection for advance therapies for PE could minimize the adverse effects and costs, while optimizing the outcomes.
Other Latest Articles
- Risk Factors for Refractory and Delayed De novo Otitis Media Requiring Pressure Equalization Tube Insertion
- The Eight Year Nasal Foreign Body: A Case Report
- Pediatric Tonsillar Malignancies: Misleading Presentations
- The Utility of a Second CT Scan in the Management of Parapharyngeal and Retropharyngeal Abscesses in Pediatric Patients
- Radiographic Findings and Clinical Correlates in Pediatric Periorbital Infections
Last modified: 2016-12-22 15:05:27